Integrated Medical & Pharmacy Atypical Antipsychotic Claims Tool (IMPACT) Real-World Evidence (RWE) Analyzer

Provides insight and generates awareness and discussion around the impact of bipolar I disorder and schizophrenia in your member population

  • The IMPACT RWE Analyzer is an interactive software tool that imports and analyzes retrospective pharmacy and medical claims to help determine the demographics, treatment utilization patterns, and associated resource use and costs of patients with schizophrenia and bipolar I disorder
  • Through the IMPACT RWE Analyzer, payers/IDNs are able to evaluate plan-specific data to better understand the management of their behavioral health population
    • The IMPACT RWE Analyzer will also allow you to evaluate your plan's performance compared with 2 national reference datasets:
      • IBM® MarketScan® Commercial with Medicare Supplemental and IBM® MarketScan® Medicaid*
    • The IMPACT RWE Analyzer evaluates 6 outcome measures:
      • Demographics, treatment utilization, adherence, treatment patterns, healthcare resource utilization, and healthcare costs
    • Through these outcomes, you can identify areas to improve your plan’s management of your schizophrenia and bipolar I disorder populations
    • Any data entered is confidential and outputs will not be utilized externally

Image is for illustrative purposes only.

*IBM is a third party provider of these national reference datasets and not affiliated with Sunovion Pharmaceuticals, Inc, or its subsidiaries.


Please talk to your Market Access Account Director directly to set up a personal demonstration of the IMPACT tool and gain access to insights into your member population.


Note: The IMPACT RWE Analyzer software does not adjust for severity of illness, certain patient demographics (eg, socioeconomic status, ethnicity, regional influences), or the clinical scenario presented to the physician at the point of service (eg, past medical history, concomitant disease states, and their management). This tool is not intended to replicate or replace Healthcare Effectiveness Data and Information Set (HEDIS) reporting or other reporting requirements for your health plan. Plan-specific data will not be viewable or accessible by Sunovion or any third parties.